Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Bairaktari

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 2, 1999
Effect of fenofibrate on serum uric acid levelsG Liamis, E T Bairaktari, M S Elisaf
European Heart Journal|December 3, 1999
Lipoprotein (a) concentrations in Greek hyperlipidaemic patients: relationship to serum lipid parametersE T Bairaktari, K Hatzidimou, M S Elisaf
Annals of Clinical Biochemistry|July 21, 2000
Aminoglycoside-induced metabolic abnormalitiesG Liamis, G Alexandridis, E T Bairaktari, et al.
Annals of Medicine|August 1, 1997
Lipoprotein (a) concentrations in patients with various dyslipidaemiasM S Elisaf, E T Bairaktari, C S Tzallas, et al.
The American Journal of Cardiology|July 21, 2001
Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemiaH J Milionis, E T Bairaktari, E N Liberopoulos, et al.
European Journal of Endocrinology|May 7, 1999
Lipoprotein (a) levels, apolipoprotein (a) phenotypes and thyroid autoimmunityE T Bairaktari, A D Tselepis, H J Millionis, et al.
Lipids|April 10, 2010
The effects of ezetimibe and/or orlistat on triglyceride-rich lipoprotein metabolism in obese hypercholesterolemic patientsE S Nakou, T D Filippatos, A P Agouridis, et al.
Journal of Cardiovascular Risk|June 3, 1999
Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemiaE T Bairaktari, C S Tzallas, V K Tsimihodimos, et al.
European Journal of Endocrinology|November 27, 2001
Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?Z Efstathiadou, S Bitsis, H J Milionis, et al.
Current Medical Research and Opinion|March 28, 2001
The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia--a pilot study involving serial samplingJ A Goudevenos, E T Bairaktari, K G Chatzidimou, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 2, 1999
Effect of fenofibrate on serum uric acid levelsG Liamis, E T Bairaktari, M S Elisaf
European Heart Journal|December 3, 1999
Lipoprotein (a) concentrations in Greek hyperlipidaemic patients: relationship to serum lipid parametersE T Bairaktari, K Hatzidimou, M S Elisaf
Annals of Clinical Biochemistry|July 21, 2000
Aminoglycoside-induced metabolic abnormalitiesG Liamis, G Alexandridis, E T Bairaktari, et al.
Annals of Medicine|August 1, 1997
Lipoprotein (a) concentrations in patients with various dyslipidaemiasM S Elisaf, E T Bairaktari, C S Tzallas, et al.
The American Journal of Cardiology|July 21, 2001
Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemiaH J Milionis, E T Bairaktari, E N Liberopoulos, et al.
European Journal of Endocrinology|May 7, 1999
Lipoprotein (a) levels, apolipoprotein (a) phenotypes and thyroid autoimmunityE T Bairaktari, A D Tselepis, H J Millionis, et al.
Lipids|April 10, 2010
The effects of ezetimibe and/or orlistat on triglyceride-rich lipoprotein metabolism in obese hypercholesterolemic patientsE S Nakou, T D Filippatos, A P Agouridis, et al.
Journal of Cardiovascular Risk|June 3, 1999
Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemiaE T Bairaktari, C S Tzallas, V K Tsimihodimos, et al.
European Journal of Endocrinology|November 27, 2001
Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?Z Efstathiadou, S Bitsis, H J Milionis, et al.
Current Medical Research and Opinion|March 28, 2001
The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia--a pilot study involving serial samplingJ A Goudevenos, E T Bairaktari, K G Chatzidimou, et al.
Pageof 2